3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
67
Recruiting
30
Terminated
26
Active not recruiting
15
Withdrawn
9
Unknown
9
Not yet recruiting
3
No longer available
2
Enrolling by invitation
2
Sponsor Class
OTHER
3
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
3
Lymphoid
3
Myeloid
2
Thoracic
1
Plasma cell
1
Other neoplasm
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
64
Lymphoma
60
Lymphoma, Follicular
55
Lymphoma, Large B-Cell, Diffuse
52
Lymphoma, B-Cell
50
Leukemia, Lymphocytic, Chronic, B-Cell
34
Lymphoma, Non-Hodgkin
33
Recurrence
28
Leukemia
22
Lymphoma, Mantle-Cell
20
Burkitt Lymphoma
20
Lymphoma, T-Cell, Peripheral
17
Leukemia, Myeloid, Acute
15
Hodgkin Disease
15
Hematologic Neoplasms
15
Waldenstrom Macroglobulinemia
14
Lymphoma, B-Cell, Marginal Zone
14
Multiple Myeloma
13
Lymphoma, T-Cell, Cutaneous
12
Lymphoma, Extranodal NK-T-Cell
12
Neoplasms
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Leukemia, B-Cell
8
Motor Activity
7
Myelodysplastic Syndromes
6
Mycosis Fungoides
6
Sezary Syndrome
5
Neoplasm, Residual
5
Pain
4
Neoplasms, Plasma Cell
4
Interventions
trametinib
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Lymphoproliferative Disorders
×
Lymphoid
×
Clear all
NCT05969821
2026-03-23
CHIS
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
5,000 enrolled
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled
NCT05718986
2024-05-08
Familial_LPD
University of Haifa
Not yet recruiting
1,000 enrolled